期刊文献+

hrHPV-DNA和p16^(INK4a)蛋白在宫颈病变中的表达 被引量:3

Expression of hrHPV-DNA and p16^(INK4a) protein in cervical lesions
下载PDF
导出
摘要 目的了解hrHPV-DNA载量及p16INK4a蛋白的表达,探讨hrHPV-DNA和p16INK4a蛋白与宫颈病变的关系,为宫颈癌早期诊断以及预测宫颈病变进展提供可靠的检测指标。方法利用第二代杂交捕获法检测hrHPV-DNA载量,采用免疫化学方法检测p16INK4a蛋白,运用检验与Spearman等级相关研究HPV-DNA和p16INK4a与宫颈病变的关系。结果随着活检分级升高,hr HPV阳性率和p16INK4a阳性表达率增高(P<0.05);正常或慢性宫颈炎中hr HPV阳性率、p16INK4a阳性表达率、HPV(+)/P16(+)表达率低于在CIN1、CIN2、CIN3、SCC中的表达(P<0.05);等级相关性分析在HPV(+)/P16(+)与活检分级呈正相关,在HPV(-)/P16(-)与活检分级呈负相关(P<0.05)。结论 hrHPV-DNA和p16INK4a蛋白均可以作为宫颈癌早期诊断的标志物。联合检测hrHPV-DNA和p16INK4a蛋白可以预测宫颈病变的进展。 【Objective】This study was to detect the infection of human papillomavirus(HPV) and the expression of p16INK4a in cervical lesions and to investigate the relevance between HPV and p16INK4a in cervical lesions.【Method】hr HPV DNA was detected by the Digene hybrid capture II system.Immunochemical method was used to detect the expression of p16INK4a.Histopathologic test was performed to identify cervical lesions of all the cases.【Results】hr HPV positive rate and p16INK4a expression increased(P 0.05) with histopathologic diagnosis increasing.The positive rates of hrHPV,p16INK4a,HPV(+)/P16(+) in negative or chronic inflammation were statistically lower than that in cervical intraepithelial neoplasia(CIN) 1,CIN2,CIN3 and squamous-cell carcinoma(SCC)(P 0.05),respectively.The expression of HPV(+)/p16(+) was positively correlated with the severity of cervical lesions(P 0.05),whereas the expression of HPV(-)/p16(-) was negatively correlated with the severity of cervical lesions(P 0.05).【Conclusions】hr HPV and p16INK4a are useful markers for the early diagnosis of cervical lesions.Combined measurement of hr HPV and p16INK4a can predict the progress of cervical lesions.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第28期3462-3465,共4页 China Journal of Modern Medicine
基金 湖南省科技厅科技计划课题(No:2010xk4032)
关键词 宫颈病变 标志物 hrHPV-DNA P16INK4A蛋白 cervical lesions markers hrHPV-DNA p16INK4a
  • 相关文献

参考文献9

  • 1PARKIN DM, BRAY F, FERLAY J, et al. Estimating the world cancer burden: Global Cancer 2000 [J]. Int J Cancer, 2001, 94: 153-156.
  • 2BOSCH FX, LORINCZ A, MUNOZ N, et al. The causal relation between human papillomavirus and cervical cancer [J]. J Clin Pathol, 2002, 55(4): 244-265.
  • 3STEBEN M, DUARTE-FRANCO E. Human papillomavirus in- fection: epidemiology and pathophysiology[J]. Gynecologic Oncolo- gy, 2007, 107(2 Suppl 1): S2-S5.
  • 4JEDPIYAWONGSE A, HOMCHA-EM P, KARALAK A, et al. Immunohistochemical overexpression of P16 protein associated with cervical cancer in Thailand [J]. Asian Pac J Cancer Prey, 2008, 9(4): 625-630.
  • 5PETO J, GILHAM C, FLETCHER O, et al. The cervical cancer epidemic that screening has prevented in the UK [J]. Lancet, 2004, 364(9430): 249-256.
  • 6HUANG MZ, LI HB, NIE XM, et al. Analysis of the dose-re- sponse relationship between high-risk human papillomavirus viral load and cervical lesians [J]. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, 103(8): 779-784.
  • 7KIM YT, ZHAO M. Aberrant cell cycle regulation in cervical carcinoma[J]. Yonsei Med J, 2005, 46(5): 597-613.
  • 8BRIGITTE S, CHRISTIANE S, NELLY B. P16 expression in re- lation to human papillomavirus in liquid-based cervical smears[J]. Gynecologic Oncology, 2008, 109(2): 285-290.
  • 9NEGRI G, VITFADELLO F, ROMANO F, et al. p16INK4a ex- pression and progression risk of low-grade intraepithelial neopla- sia of the cervix uteri[J]. Virchows Arch, 2004, 445(6): 616-620.

同被引文献34

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部